Chemoprvention traials in the cervix: Design, feasibility, and recruitment
- 1 January 1995
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 59 (S23) , 104-112
- https://doi.org/10.1002/jcb.240590914
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Interim Guidelines for Management of Abnormal Cervical CytologyJAMA, 1994
- Mechanistic considerations in chemopreventive drug developmentJournal of Cellular Biochemistry, 1994
- Chemoprevention of cancerThe Lancet, 1993
- Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial NeoplasiaJNCI Journal of the National Cancer Institute, 1993
- Chemoprevention clinical trialsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1992
- Oral folic acid supplementation for cervical dysplasia: A clinical intervention trialAmerican Journal of Obstetrics and Gynecology, 1992
- The natural history of intraepithelial neoplasia: Relevance to the search for intermediate endpoint biomarkersJournal of Cellular Biochemistry, 1992
- Role of Epidemiology in Defining Events That Influence Transmission and Natural History of Anogenital Papillomavirus InfectionsJNCI Journal of the National Cancer Institute, 1991
- The 1988 Bethesda System for Reporting Cervical/Vaginal Cytological DiagnosesJAMA, 1989
- Evaluation of topically applied trans-retinoic acid in the treatment of cervical intraepithelial lesionsAmerican Journal of Obstetrics and Gynecology, 1982